NO20091239L - Konjugater av disorazoler og deres derivater med celle bindingsmolekyler, nye disorazol derivater, fremgangsmate for fremstilling og anvendelse derav - Google Patents
Konjugater av disorazoler og deres derivater med celle bindingsmolekyler, nye disorazol derivater, fremgangsmate for fremstilling og anvendelse deravInfo
- Publication number
- NO20091239L NO20091239L NO20091239A NO20091239A NO20091239L NO 20091239 L NO20091239 L NO 20091239L NO 20091239 A NO20091239 A NO 20091239A NO 20091239 A NO20091239 A NO 20091239A NO 20091239 L NO20091239 L NO 20091239L
- Authority
- NO
- Norway
- Prior art keywords
- derivatives
- conjugates
- disorazoles
- binding molecules
- cell binding
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Foreliggende oppfinnelse tilveiebringer konjugater av disorazoler og deres derivater med cellebindingsmolekyler, slike som peptider, proteiner, hormoner, blodprotemer og antistoffer. Foreliggende oppfinnelse tilveiebringer videre nye disorazolderivater og fremgangsmåter for fremstilling av slike konjugater og disorazolderivater. Disse forbindelsene kan anvendes som medikamenter for behandling av fysiologiske og/eller patofysiologiske tilstander hos pattedyr, særlig for behandling av forskjellige tumorer.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84235706P | 2006-09-06 | 2006-09-06 | |
EP06018750A EP1900742A1 (en) | 2006-09-07 | 2006-09-07 | Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof |
PCT/EP2007/059310 WO2008028934A1 (en) | 2006-09-06 | 2007-09-06 | Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20091239L true NO20091239L (no) | 2009-06-10 |
Family
ID=41706619
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20091239A NO20091239L (no) | 2006-09-06 | 2009-03-25 | Konjugater av disorazoler og deres derivater med celle bindingsmolekyler, nye disorazol derivater, fremgangsmate for fremstilling og anvendelse derav |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP5340155B2 (no) |
HK (1) | HK1134812A1 (no) |
HR (1) | HRP20160631T1 (no) |
IL (1) | IL197127A (no) |
NO (1) | NO20091239L (no) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8877202B2 (en) * | 2013-02-07 | 2014-11-04 | Immunomedics, Inc. | Pro-drug form (P2PDOX) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5843903A (en) * | 1995-11-27 | 1998-12-01 | The Administrators Of The Tulane Educational Fund | Targeted cytotoxic anthracycline analogs |
AU4267700A (en) * | 2000-01-13 | 2001-07-19 | Academia Sinica | Application of somatostatin analogs to specific delivery of anti-tumor drugs into tumor cells |
BR0313789A (pt) * | 2002-08-24 | 2005-07-05 | Zentaris Gmbh | Medicamento contendo disorazóis e seus derivados para o tratamento de doenças tumorais malignas e benignas |
NZ550934A (en) * | 2004-05-19 | 2010-05-28 | Medarex Inc | Chemical linkers and conjugates thereof |
EP1743897A1 (en) * | 2005-07-15 | 2007-01-17 | Gesellschaft für Biotechnologische Forschung mbH | Biologically active compounds obtainable from Sorangium cellulosum |
-
2007
- 2007-09-06 JP JP2009527139A patent/JP5340155B2/ja not_active Expired - Fee Related
-
2009
- 2009-02-19 IL IL197127A patent/IL197127A/en not_active IP Right Cessation
- 2009-03-25 NO NO20091239A patent/NO20091239L/no not_active Application Discontinuation
- 2009-12-18 HK HK09111963.1A patent/HK1134812A1/xx not_active IP Right Cessation
-
2016
- 2016-06-08 HR HRP20160631TT patent/HRP20160631T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
HK1134812A1 (en) | 2010-05-14 |
JP2010502673A (ja) | 2010-01-28 |
IL197127A (en) | 2016-06-30 |
HRP20160631T1 (hr) | 2016-07-15 |
JP5340155B2 (ja) | 2013-11-13 |
IL197127A0 (en) | 2009-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1120670T1 (el) | Μονοκλωνικα αντισωματα εναντι του αναστολεα μονοπατιου ιστικου παραγοντα (tfpi) | |
BR112012025568A2 (pt) | proteínas de ligação ao tnf-<244>. | |
BR112014010161A2 (pt) | anticorpo monoclonal antiproteína de ligação ao dna tar de 43 kda (tdp-43) e seus método de preparação e uso no tratamento de proteinopatia tdp-43, bem como composições, polinucleotídeo, método in vitro e kit para diagnosticar proteinopatia tdp-43 | |
PH12018500641A1 (en) | Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi) | |
BR112015014751A2 (pt) | anticorpos anti-tau humanos | |
EA201170635A1 (ru) | Композиции, способы получения и применение каркаса на основе домена фибронектина типа iii | |
BR112014032999A2 (pt) | optimização de anticorpos que ligam o gene de ativação de linfócito 3 (lag-3), e uso dos mesmos | |
MX2013002379A (es) | Moleculas de union a vegf. | |
ATE473438T1 (de) | Zuführung von molekülen an eine lipiddoppelschicht | |
BRPI1008145A2 (pt) | proteína de ligação de antígeno biespecífico, método para preparação de uma proteína de ligação de antígeno biespecífico, célula hospedeira, composição farmacêutica, uso da proteína de ligação de antígeno biespecífico e método para o tratamento de um paciente. | |
NO20082960L (no) | Ligander med bindingsspesifisitet for VEGF og/eller EGFR og fremgangsmater for anvendelse derav | |
BR112012031727A2 (pt) | conjugado de droga-anticorpo, composição farmacêutica, uso do conjugado de droga-anticorpo, método para induzir a eliminação celular ou inibir o crescimento e/ou a proliferação de uma célula tumoral, e, método de tratamento de doença. | |
ATE537188T1 (de) | Serumalbuminbindende proteine | |
EA201200548A1 (ru) | Биспецифические связывающие молекулы для антиангиогенезной терапии | |
TR201908638T4 (tr) | Ang2 bağlayıcı moleküller. | |
EA200601946A3 (ru) | Антитела, связывающиеся с белками steap-1, и их производные | |
MX337358B (es) | Conjugados de disorazoles y sus derivados con moleculas de union con celulas, nuevos derivados de disorazol, procesos de fabricacion y usos de los mismos. | |
BRPI0720879A2 (pt) | microvesícula derivada de fermento carreador de fator de tecido (tf), composição e composição farmacêutica que a compreende, processos para a sua manufatura, proteína lipida de fator de tecido (tf) modificado, polinucleotídeo, vetor, célula hospedeira e anticorpo. | |
CL2008003357A1 (es) | Procedimiento para obtener una solucion de albumina humana con alta capacidad de union de moleculas que comprende una diafiltracion, estabilizacion con nacl y aminoacidos sin adicion de acidos grasos, pasteurizacion y una segunda diafiltracion. | |
WO2010099139A3 (en) | Combination of an either an anti-igf-ir- antibody or an igf binding protein and a small molecule igf-ir kinease inhibitor | |
WO2014102299A3 (en) | Anti-lamp1 antibodies and antibody drug conjugates, and uses thereof | |
WO2008143812A3 (en) | Biologic devices for hemostasis | |
DK1869185T3 (da) | Konjugat med P21-protein til kræftbehandling | |
WO2009095452A8 (en) | Crystal structure of the atpase domain of proteins of the hsp70 family | |
NO20091239L (no) | Konjugater av disorazoler og deres derivater med celle bindingsmolekyler, nye disorazol derivater, fremgangsmate for fremstilling og anvendelse derav |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Reestablishment of rights (par. 72 patents act) | ||
FC2A | Withdrawal, rejection or dismissal of laid open patent application |